Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
140 people get NURO articles and Market Currents by email alert.
Get email alerts on NURO »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (Apr 25, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 15, 2013)
-
Business Wire (Feb 12, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 7, 2013)
-
Business Wire (Jan 2, 2013)
-
Business Wire (Nov 29, 2012)
-
Business Wire (Nov 27, 2012)
-
Business Wire (Nov 1, 2012)
-
Business Wire (Oct 25, 2012)
-
Business Wire (Oct 15, 2012)
-
Business Wire (Sep 20, 2012)
-
Business Wire (Sep 5, 2012)
-
To learn more about Seeking Alpha Pro, click here.
-
-
New Product Launch May Send NeuroMetrix For A RideAlex Shadunsky • Fri, Dec 16, 2011 -
-
NeuroMetrix: Revenues Decline, Prospects Look BleakDouglas Cress • Thu, Aug 7, 2008 -
NeuroMetrix: Cost Cutting and New Products Not Appeasing InvestorsDouglas Cress • Thu, Jul 31, 2008
-
-
-
-
-
-
-
-
Medical Device Trades: 7 Stocks Under 5 BucksMike Havrilla • Mon, Jul 6, 2009 -
-
-
-
Earnings Winners and Losers (Week Ending 2/15)Bespoke Investment Group • Sun, Feb 17, 2008
-
Business Wire (Apr 25, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 15, 2013)
-
Business Wire (Feb 12, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 7, 2013)
-
Business Wire (Jan 2, 2013)
-
Business Wire (Nov 29, 2012)
-
Business Wire (Nov 27, 2012)
-
Business Wire (Nov 1, 2012)
-
Business Wire (Oct 25, 2012)
-
Business Wire (Oct 15, 2012)
-
Business Wire (Sep 20, 2012)
-
Business Wire (Sep 5, 2012)
-
Business Wire (Aug 6, 2012)
-
Business Wire (Jul 26, 2012)
-
Business Wire (Jul 19, 2012)
NURO vs. ETF Alternatives
Company Description
Currently, there's no company description for NURO.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, April 25, 11:35 AM NeuroMetrix (NURO): Q1 EPS of -$1.06. Revenue of $1.4M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, February 19, 7:10 AM NeuroMetrix (NURO) Q4 EPS of -$0.89 misses by $0.67. Revenue of $1.52M misses by $0.3M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Monday, August 6, 2012, 1:36 PM NeuroMetrix (NURO +17%) jumps after announcing it's received FDA clearance to market its Sensus Pain Management device in the U.S. market. The device is intended for use as a transcutaneous electrical nerve stimulator for the symptomatic relief and management of chronic intractable pain. Comment! [Healthcare, On the Move]